Vimarsana
Biggest News Aggregation in the World

Page 35 - Divi Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Divi Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Divi Lab Today - Breaking & Trending Today

Stock Market Updates (April 4, 2021): Sensex Tumbles Over 400 Points, Nifty Slips Below 14,500 - Vimarsana News

Stock Market Updates (April 4, 2021): Sensex Tumbles Over 400 Points, Nifty Slips Below 14,500

Sensex Tumbles Over 400 Points, Nifty Settles Below 14,500 Tata Consumer Products dived nearly 5 per cent to top the loser's list on the BSE, while pharma stocks such as Cipla, Dr Reddy's and Divi's Lab lost 1-3 per cent each Updated: May 04, 2021 3:40 pm IST Cipla, Dr Reddy's, Divi's Lab and Sun Pharma lost 1-3 per cent each on the BSE The benchmark indices tumbled nearly one per cent in the late-afternoon session to end near the lows of the day, amid heightened volatility. The BSE Sensex swung in a range of more than 800 points before ending the session at 48,253.51, weaker by 465.01 ...

Source: ndtv.com
Stock Market Updates (April 30, 2021): Sensex Plunges Over 700 Points; Banking Stocks Lead Losses - Vimarsana News

Stock Market Updates (April 30, 2021): Sensex Plunges Over 700 Points; Banking Stocks Lead Losses

The Bank index was the top sectoral loser on the BSE, shedding over 2 per cent. The benchmark indices have slipped more than a per cent in the afternoon session to trade near the lows of the day, as fears surrounding the mounting Covid cases came back to haunt the market participants after a four-day rally. At 1:45 pm, the BSE Sensex was trading at 49,064.45, lower by 700.05 points or 1.33 per cent and the NSE Nifty was at 14,715.25, down 163.45 points or 1.30 per cent. The Bank index was the top sectoral loser on the BSE, shedding over 2 per cent. The BSE Midcap and BSE Smallcap indices howe...

Source: ndtv.com
pharma stocks: Pharma stocks momentum is not going to abate anytime soon - Vimarsana News

pharma stocks: Pharma stocks momentum is not going to abate anytime soon

Explore Now Nifty and Bank Nifty have failed to break past that gap down, which was created post the Monday selling and that has really hurt the sentiments for the indices, says the independent market expert Kunal Bothra. Excerpts from an interview: We had a scary Monday and since then we saw a steady rebound coming in. Is the rebound enough for us to not test Monday’s lows of 14,320? We saw more of a repel trade or a repair mode in the second half of the week. The Monday selloff put in quite a dent into the indices. If you look at the momentum, there is hardly any major build up of open in...

LIC betting on old economy stocks - The Hindu BusinessLine - Vimarsana News

LIC betting on old economy stocks - The Hindu BusinessLine

LIC betting on old economy stocks Buys shares worth ₹3,000 crore in at least 15 companies The biggest domestic institutional investor LIC has upped holdings in at least 15 companies by buying shares worth ₹3,000 crore during January-March quarter even as markets rose nearly 4 per cent. LIC has hiked stakes in old economy sector companies such as those involved in manufacture of cement, auto ancillaries, chemicals, energy and paints. However, it also appears to have booked profits partly in select PSU bank stocks, Tata Steel and TCS etc., many of whom had seen a healthy rise in price durin...

Best stocks to buy: IT midcaps are good but Neeraj Dewan prefers largecaps now - Vimarsana News

Best stocks to buy: IT midcaps are good but Neeraj Dewan prefers largecaps now

Explore Now Among largecaps, HCL Technology makes sense valuation wise and there are a lot of opportunities in midcaps also, says Quantum Securities. From a valuation standpoint, how does IT stack up and would you be also looking at a lot of the midcap IT names? Neeraj Dewan: We were looking at midcap IT but after the correction in largecap IT, it makes sense to invest more in IT largecaps. The last quarter’s numbers were pretty good and even the deal wins are good. Stocks like TCS, HCL Tech, Oracle have corrected a little more than 10%. That is a good entry for a lot of investors who had...